ArticleInternational journal of clinical pharmacy2023
Patient experiences and opinions on medication review: a qualitative study.
Article in International journal of clinical pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 11 citations in OpenAlex.
- Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study.Exploratory research in clinical and social pharmacy · 2026Article
- Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study.International journal of clinical pharmacy · 2025Article
- Streamlining the quality assessment in medication reviews: a biased random sampling approach using BRANT-MERQS criteria.International journal of clinical pharmacy · 2025Article
- Attitudes and expectations toward medication review among community pharmacy customers in Germany: a cross-sectional study.Journal of pharmaceutical policy and practice · 2025Article
- Implementation of medication review type 2a in community pharmacies: a longitudinal survey study.Frontiers in pharmacology · 2025Article
- [New tools for medication review: DRP in patients treatment with proton pump inhibitors].Atencion primaria · 2024Observational
- Medication Review: What's in a Name and What Is It about?Pharmacy (Basel, Switzerland) · 2024Review
- Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus.Frontiers in pharmacology · 2024Article
- Key elements in the quality assessment of a type 3 medication review.Frontiers in pharmacology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMedication reviews are a structured critical evaluation of a patient's pharmacotherapy, carried out by a healthcare professional, but are not yet a routine pharmaceutical service in Belgium. A pilot project to initiate an advanced medication review (= type 3 medication review) in community pharmacies was set up by the Royal Pharmacists' Association of Antwerp.
aimTo investigate the experiences and opinions of patients who participated in this pilot project.
methodQualitative study through semi-structured interviews with participating patients.
resultsSeventeen patients from six different pharmacies were interviewed. The medication review process with the pharmacist was perceived as positive and instructive by fifteen interviewees. The extra attention that the patient received was highly appreciated. However, the interviews revealed that patients did not fully understand the purpose and structure of this new service or were aware of the subsequent contact and feedback with the general practitioner. Medication reviews in the home setting put patients more at ease, were highly appreciated, and enabled also to address practical problems such as drug dosing or storage requirements.
conclusionThis qualitative study analysed patients' experiences during a pilot project on the implementation of type 3 medication review. Although most patients were enthusiastic about this new service, a lack of patients' understanding of the whole process was also observed. Therefore, better communication to patients by pharmacists and general practitioners about the goals and components of this type of medication review is needed, with the added benefit of increased efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.